Immediate Impact

3 by Nobel laureates 4 from Science/Nature 89 standout
Sub-graph 1 of 22

Citing Papers

Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
2023 Standout
European Association of Urology Guidelines on Testicular Cancer: 2023 Update
2023 Standout
4 intermediate papers

Works of R. Delva being referenced

A Risk-adapted Study of Cisplatin and Etoposide, with or Without Ifosfamide, in Patients with Metastatic Seminoma: Results of the GETUG S99 Multicenter Prospective Study
2013
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)
2007
and 1 more

Author Peers

Author Last Decade Papers Cites
R. Delva 296 254 160 178 23 570
Donia McLemore 177 153 282 154 19 544
Helen Patterson 202 121 197 146 23 469
Anna Felisiak-Gołąbek 197 89 205 94 20 538
Raffaele Cozza 115 103 150 104 38 534
Junyan Xu 259 158 157 167 31 649
Qun-Li Shi 205 118 259 84 41 574
Isamu Hayashi 172 118 212 128 20 504
Kazunori Nishida 345 95 310 63 22 637
Biao Liu 174 197 204 68 35 590
Shih-Chen Yu 141 116 251 69 15 576

All Works

Loading papers...

Rankless by CCL
2026